BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  VectivBio Receives FDA Orphan Drug Designation for Apraglutide for Acute Graft-Versus-Host DiseasePhase 2 trial expected to begin in the first quarter of 2022

  VectivBio Holding AG today announced that the FDA has granted orphan drug designation to apraglutide, a next-generation, long-acting GLP-2 analog being developed for rare gastrointestinal (GI) diseases.

  June 24, 2021

   · 

  4 min read
• Endo’s Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021

  Endo International plc data will be presented during Cosmetic Bootcamp Summer Event 2021.

  June 24, 2021

   · 

  7 min read
• Biotech Beach

  HUYABIO Announces HBI-8000 Brand Name of Hiyasta™

  HUYABIO International announced today that HBI-8000 will be marketed under the brand name Hiyasta ™ in Japan .

  June 24, 2021

   · 

  2 min read
• FDA

  Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer

  Pieris Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to cinrebafusp alfa (PRS-343), a 4-1BB/HER2 bispecific, for the treatment of HER2-high and HER2-low expressing gastric cancers.

  June 24, 2021

   · 

  5 min read
• BioMidwest

  Assure Holdings Supports Rare Auditory Brainstem Implant Surgery

  Assure Holdings Corp., a provider of intraoperative neuromonitoring services, is pleased to announce that it supported a successful auditory brainstem implant surgery.

  June 24, 2021

   · 

  4 min read
• Business

  Integra LifeSciences Announces CEO Succession PlanPeter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor

  Integra LifeSciences Holdings Corporation today announced that Peter Arduini will step down as Chief Executive Officer at the end of 2021 to accept the role of President and Chief Executive Officer of GE Healthcare.

  June 24, 2021

   · 

  3 min read
• Deals

  Gliknik Inc. Raises $11.5 Million in Series C Financing

  Gliknik Inc. today announced that it has successfully completed an $11.5 million Series C Preferred Stock financing.

  June 24, 2021

   · 

  2 min read
• Pharm Country

  PANTHERx® Rare Pharmacy Selected by Rhythm Pharmaceuticals to Distribute IMCIVREE™ (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

  PANTHERx ® Rare Pharmacy announced today that it was selected by Rhythm Pharmaceuticals as the exclusive U.S. pharmacy distribution partner for IMCIVREE ™ (setmelanotide).

  June 24, 2021

   · 

  4 min read
• Pharm Country

  Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

  Synaptogenix, Inc. today announced that Dr. Daniel Alkon , the Company’s President and Chief Scientific Officer, will appear as a featured guest on TD Ameritrade Network’s “The Watch List” on Friday, June 25, 2021 at 1:20 pm ET

  June 24, 2021

   · 

  3 min read
• Business

  Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China

  The formal launch of the BGI/Natera Signatera Assay is the next step towards achieving global access to personalized ctDNA testing

  June 24, 2021

   · 

  5 min read